Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 12, 2021

View Archived Issues

HepaRegeniX initiates first-in-human trial of HRX-0215

China Pharmaceutical University targets WDR5/MLL1 interaction with DDO-2213

GentiBio closes Series A financing to advance its pipeline of engineered Treg therapies

First patient dosed in phase I study of AVA-6000

IN8bio completes dosing of first cohort in phase I study of INB-100

Janssen describes mutant FimH compositions

Positive interim analysis data from phase II/III study of plonmarlimab in severe COVID-19

Jiangsu Hengrui Medicine and collaborators patent antibacterials

New PTPN11 inhibitors discovered at Betta Pharmaceuticals

Nuvation Bio identifies new adenosine A2a receptor antagonists

SAB-185 potently neutralizes delta and lambda SARS-CoV-2 variants in nonclinical studies

Oxford Vacmedix receives approval for its first-in-human study of OVM-200 cancer vaccine

Lynk initiates dosing in phase I study of its triple-kinase inhibitor LNK-01002

RemeGen completes phase II study of telitacicept in IgAN

FDA clears IND for XeriSol levothyroxine subcutaneous injection

Imatinib preserves Beta-cell function in subjects with type 1 diabetes

Cali Biosciences initiates MERIT-1 study of long-acting ropivacaine for postoperative pain

Further data from phase I study of UV-1 in metastatic melanoma

JadiCell shows superior neurogenesis induction in model of viral-induced cognitive dysfunction

Algernon Pharmaceuticals announces SCLC research program for ifenprodil

Enrollment ongoing in phase II studies of ABBV-154

Marker of neuroaxonal injury is also a marker of worse outcomes in COVID-19 patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...